Related references
Note: Only part of the references are listed.Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats
Saadet Turkseven et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Guido Carpino et al.
HEPATOLOGY (2020)
Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling
Seung Kak Shin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure
Cornelius Engelmann et al.
JOURNAL OF HEPATOLOGY (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The cardioprotective effects of icariin on the isoprenaline-induced takotsubo-like rat model: Involvement of reactive oxygen species and the TLR4/NF-κB signaling pathway
Chunlei Qi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Alisol B 23-Acetate Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction by Suppressing Toll-Like Receptor 4 (TLR4)/NADPH Oxidase 2 (NOX2) Signaling Pathway
BinYan Wang et al.
MEDICAL SCIENCE MONITOR (2019)
Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis
Hirotaka Furuhashi et al.
HEPATOLOGY RESEARCH (2018)
Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways
Fengyan Cao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Vitamin A-coupled liposomes carrying TLR4-silencing shRNA induce apoptosis of pancreatic stellate cells and resolution of pancreatic fibrosis
Yuwei Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Matrix metalloproteinase functions in hepatic injury and fibrosis
Martin Roderfeld
MATRIX BIOLOGY (2018)
Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-κB and TGF-β1/Smad2 Signaling Pathways
Liteng Lin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
Swati Bhattacharyya et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gut microbiota and Toll-like receptors set the stage for cytokine-mediated failure of antibacterial responses in the fibrotic liver
Christian Kuntzen et al.
GUT (2017)
Modulation of hepatic stellate cells and reversibility of hepatic fibrosis
Yu Huang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Protective effects of morin on lipopolysaccharide/D-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways
Ye Tian et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
Zhenhua Ma et al.
PLOS ONE (2017)
Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
Positive Feedback regulation between Transglutaminase 2 and Toll-like receptor 4 signaling in hepatic stellate cells correlates with liver Fibrosis Post Schistosoma japonicum infection
Zhencheng Wen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Polydatin protects against carbon tetrachloride-induced liver fibrosis in mice
Xinyi Zhao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice Role of Hepatic Stellate Cells
Sudhir Kumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Liver Fibrosis: From Pathogenesis to Novel Therapies
Ralf Weiskirchen et al.
DIGESTIVE DISEASES (2016)
Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy
Anish Babu et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2016)
Pulmonary administration of small interfering RNA: The route to go?
M. J. R. Ruigrok et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Delivery of RNAi Therapeutics to the AirwaysFrom Bench to Bedside
Yingshan Qiu et al.
MOLECULES (2016)
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Chong-Yang Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
RNA interference in the treatment of renal stone disease: Current status and future potentials
Kyle D. Wood et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway
Lei Liang et al.
ONCOTARGET (2016)
Cancer and liver cirrhosis: implications on prognosis and management
Matthias Pinter et al.
ESMO OPEN (2016)
Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells
Yangyang Ouyang et al.
FIBROGENESIS & TISSUE REPAIR (2016)
MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways
Yuhan Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Toll-like receptors in pathophysiology of liver diseases
Safak Kiziltas
WORLD JOURNAL OF HEPATOLOGY (2016)
Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro
Yiping Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
Dan Li et al.
EJNMMI RESEARCH (2015)
Isolation and culture of hepatic stellate cells from mouse liver
Wenju Chang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
Inhibition of Toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection
Shingo Oya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
E2F1 Is a Novel Fibrogenic Gene That Regulates Cholestatic Liver Fibrosis Through the Egr-1/SHP/EID1 Network
Yuxia Zhang et al.
HEPATOLOGY (2014)
Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes
Hirotoshi Ishiwatari et al.
GUT (2013)
Hepatic Stellate Cell-Targeted Delivery of Hepatocyte Growth Factor Transgene via Bile Duct Infusion Enhances Its Expression at Fibrotic Foci to Regress Dimethylnitrosamine-Induced Liver Fibrosis
Balakrishnan Chakrapani Narmada et al.
HUMAN GENE THERAPY (2013)
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
Yoon Seok Roh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
被撤回的出版物: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)
Fu-ping Wang et al.
PLOS ONE (2013)
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Derrick E. Fouts et al.
JOURNAL OF HEPATOLOGY (2012)
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice
Timea Csak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Viral vector-mediated RNA interference
Linda B. Couto et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Liver fibrosis - Pathogenesis and novel therapeutic approaches
F. Tacke et al.
INTERNIST (2010)
Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview
Zinnia P. Parra-Guillen et al.
PHARMACEUTICAL RESEARCH (2010)
Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies
Jing-Ting Li et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells
YH Paik et al.
HEPATOLOGY (2003)
Share Paper
